How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in Texas

NMN and NR: What Texas Patients Need to Know About NAD+ Precursors

Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are biosynthetic precursors to nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in over 500 enzymatic reactions governing cellular energy metabolism, DNA repair, and sirtuin activation. NAD+ tissue concentrations decline roughly 50% between ages 40 and 60 in human skeletal muscle samples [1].

Yoshino et al. published a randomized, controlled trial in Science (2021, N=25 postmenopausal women with prediabetes) showing that 250 mg/day of oral NMN for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25% compared to placebo, measured by hyperinsulinemic-euglycemic clamp [1]. A separate 12-week RCT by Martens et al. (2018, N=24) found that NR at 1,000 mg/day raised NAD+ levels in whole blood by roughly 60% and reduced systolic blood pressure by a mean of 3.4 mmHg in healthy middle-aged and older adults [2].

These compounds sit in a regulatory gray zone. The FDA has not approved NMN or NR as prescription drugs, yet prescription-grade formulations compounded under Section 503A of the Federal Food, Drug, and Cosmetic Act are legally dispensed in Texas when a valid patient-prescriber relationship exists. This distinction matters for Texans seeking pharmaceutical-quality products rather than unregulated dietary supplements.

Texas Telehealth Rules for NMN/NR Prescriptions

Texas permits telehealth prescribing for NMN and NR under the state's telemedicine framework, provided the encounter uses synchronous audio-video communication. The Texas Medical Board requires that a bona fide physician-patient relationship be established before any prescription is issued, but this relationship can be formed entirely via a live video visit [3].

No in-person visit is required as a prerequisite. A Texas-licensed prescriber conducts a medical history review, evaluates baseline lab work, discusses goals (longevity support, metabolic optimization, or cellular energy), and then writes the prescription electronically to a 503A compounding pharmacy. The Texas Occupations Code, Section 111.005, explicitly authorizes this workflow for non-controlled substances [3].

One practical point: Texas insurance carriers, including Texas Medicaid, do not cover NMN or NR for longevity or NAD+ precursor indications. Coverage exists only for narrow type 2 diabetes contexts, and even that pathway is rarely approved. Most Texas patients pay cash, with compounded NMN typically ranging from $90 to $200 per month depending on dose and pharmacy.

Who Can Prescribe NMN/NR in Texas: MDs, NPs, and PAs

Three prescriber categories in Texas hold authority to write NMN/NR prescriptions. Medical doctors (MDs) and doctors of osteopathic medicine (DOs) have unrestricted prescriptive authority for non-controlled substances. Nurse practitioners (NPs) who have completed the required 1,000 hours of supervised practice under a Texas-licensed physician and hold prescriptive authority from the Texas Board of Nursing may also prescribe [4]. Physician assistants (PAs) prescribe under a supervisory agreement with a licensed physician, per the Texas Physician Assistant Board rules.

The prescriber must hold an active Texas license or a license in a state that has entered into a telehealth interstate compact recognized by Texas. A California-licensed MD cannot write a Texas prescription without appropriate cross-state authorization. HealthRX physicians are licensed in Texas and prescribe NMN/NR via the platform's telehealth workflow.

For patients transitioning from another state, Texas does not automatically honor out-of-state NMN/NR prescriptions filled at compounding pharmacies. A new consultation with a Texas-licensed prescriber is the cleanest path to uninterrupted access.

Required Labs Before Starting NMN/NR in Texas

A responsible prescriber will order baseline labs before writing an NMN or NR prescription. These are not mandated by Texas law but are considered standard practice in longevity medicine protocols.

The typical pre-treatment lab panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting insulin, fasting glucose, hemoglobin A1c, and a lipid panel. Some clinicians add an intracellular NAD+ metabolite assay, though this test remains expensive ($150 to $300 out-of-pocket) and is not universally available at Texas commercial lab chains [5].

Martens et al. tracked safety markers across their 12-week NR trial and reported no clinically significant adverse events, no liver enzyme elevations, and no changes in renal function at 1,000 mg/day [2]. Yoshino et al. similarly reported that 250 mg/day NMN was well tolerated with no serious adverse events over 10 weeks [1]. These safety profiles support the lab monitoring approach rather than frequent repeat testing, with follow-up labs at 90 days being a common interval.

Patients with active liver disease, those on warfarin (due to theoretical NAD+ pathway interactions with coagulation), or individuals undergoing chemotherapy should receive more thorough evaluation before initiation. The Endocrine Society has not issued formal guidelines on NAD+ precursor supplementation, so prescribers rely on emerging trial data and clinical judgment [6].

503A Compounding Pharmacies in Texas: How the Supply Chain Works

Texas has a well-established 503A compounding pharmacy infrastructure regulated by the Texas State Board of Pharmacy. These pharmacies compound NMN and NR pursuant to individual patient prescriptions, using bulk pharmaceutical-grade raw materials that meet USP standards [7].

The 503A pathway differs from 503B outsourcing facilities. A 503A pharmacy compounds medications after receiving a specific patient prescription. A 503B facility can produce larger batches without patient-specific prescriptions but operates under stricter FDA oversight. Both exist in Texas, though most telehealth NMN/NR prescriptions route through 503A pharmacies.

Texas 503A pharmacies may ship compounded NMN/NR directly to a patient's home address anywhere within the state. Interstate shipping from a Texas 503A pharmacy is also permissible when the pharmacy holds the appropriate licenses in the destination state. Typical compounding turnaround is 3 to 5 business days after the pharmacy receives the prescription, followed by 2 to 4 days for shipping.

Quality varies between compounding pharmacies. Patients should verify that the pharmacy holds current Texas State Board of Pharmacy accreditation and, ideally, voluntary third-party accreditation from the Pharmacy Compounding Accreditation Board (PCAB). HealthRX partners with PCAB-accredited pharmacies for all NAD+ precursor prescriptions.

NMN vs. NR: Which NAD+ Precursor Do Texas Prescribers Favor?

Both NMN and NR raise intracellular NAD+ levels, but they enter the biosynthetic pathway at different points. NR is converted to NMN by nicotinamide riboside kinases (NRK1/NRK2), and NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNATs). NMN skips the NRK step [8].

A head-to-head pharmacokinetic study published in Nature Communications (Pencina et al., 2023, N=36) compared single-dose oral NMN (900 mg) to NR (1,000 mg) in healthy adults. Both compounds raised whole-blood NAD+ levels by 90 days, with NMN producing a faster peak at 2 to 4 hours versus NR's peak at 4 to 8 hours [9]. Neither compound demonstrated clear superiority in sustained NAD+ elevation at the 90-day mark.

Texas prescribers writing through telehealth platforms typically default to NMN in the 250 to 500 mg/day oral capsule range, based on the Yoshino trial's dosing [1]. NR at 300 to 1,000 mg/day remains the alternative when patients prefer the compound with a longer publication track record. Sublingual formulations of NMN are also available from Texas compounding pharmacies and may offer improved bioavailability by bypassing first-pass hepatic metabolism, though no large RCT has confirmed this advantage.

Timeline: From Consultation to Delivery in Texas

The complete process for a Texas resident obtaining NMN/NR through telehealth follows a predictable timeline.

Day 1 involves completing an intake form and scheduling a telehealth consultation. Most platforms, including HealthRX, offer same-day or next-day appointments for Texas patients. Labs can be drawn at any Quest, Labcorp, or independent draw site across the state. Results return in 1 to 3 business days for standard panels.

The prescriber reviews labs and conducts the video consultation, typically lasting 15 to 25 minutes. If NMN or NR is appropriate, the electronic prescription transmits directly to the compounding pharmacy. Compounding takes 3 to 5 business days. Shipping within Texas (USPS Priority or FedEx) adds 2 to 4 business days.

Total elapsed time from initial intake to receiving the first shipment: 7 to 14 business days. Refills process faster because labs and the patient relationship are already established. Most patients receive refills within 5 to 7 business days.

Cost Breakdown for NMN/NR in Texas

Because Texas Medicaid and most commercial insurers do not cover NMN/NR for longevity indications, out-of-pocket cost transparency matters. A 30-day supply of compounded NMN at 250 mg/day runs approximately $90 to $130 from Texas 503A pharmacies. At 500 mg/day, expect $150 to $200. NR at 300 mg/day falls in the $80 to $120 range, scaling with dose.

Telehealth consultation fees vary. HealthRX charges a flat consultation fee that includes follow-up messaging and prescription management. Some providers charge per-visit, ranging from $75 to $150 per encounter. Lab costs at commercial draw sites run $50 to $200 depending on the panel, though many telehealth platforms offer bundled pricing.

Compared to over-the-counter NMN supplements (which range from $40 to $90 per month), prescription-compounded NMN costs more. The difference buys USP-grade ingredients, third-party potency testing, pharmacist oversight, and a prescriber monitoring your labs and clinical response. A 2022 analysis of 22 commercially available NMN supplements found that only 68% contained the labeled dose within a 10% tolerance [10].

Prior Authorization and Insurance Considerations in Texas

Prior authorization for NMN/NR is rarely relevant in Texas because the dominant payment model is direct-pay. Texas Medicaid does not cover NMN or NR for longevity, anti-aging, or general NAD+ optimization. Coverage consideration exists only for compounded formulations prescribed for a type 2 diabetes indication, and even in this narrow scenario, prior authorization requires documentation of at least two failed first-line therapies (typically metformin and a sulfonylurea or GLP-1 agonist), recent A1c values, and prescriber attestation of medical necessity.

For the rare patient pursuing an insurance claim, the documentation package includes the prescribing clinician's letter of medical necessity, lab results demonstrating metabolic dysfunction, and evidence that the compounded formulation differs meaningfully from commercially available alternatives. The Texas Department of Insurance does not mandate coverage of compounded medications, leaving this entirely to individual carrier discretion.

The practical reality: fewer than 5% of Texas NMN/NR patients attempt insurance billing. Cash pay eliminates administrative friction and speeds the process by 1 to 2 weeks.